RxDoctor Payments Data

Robert Eastwood, PA

Physician Assistant · Shreveport, LANPI 1427269893

Payments from drug & device makers

$816in general payments, 2019–2025

Across 51 payments — averaging $16.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$280
  • AstraZeneca$103
  • Novo Nordisk$102
  • Dexcom, Inc.$90
  • Bayer$45
  • Pfizer$43
  • plus $153 from 8 others

What the payments were for

  • Food & beverage$79597%
  • Education$203%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$816 in reported general payments places this provider in the 65th percentile of 1,246 physician assistant providers in Louisiana.

See all physician assistant providers in Louisiana

Medicare billing

Part B allowed, 2024
$45,071
Medicare patients
232
Services billed
774

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide15$22,366
EliquisApixaban28$20,871
MounjaroTirzepatide16$18,045
JanuviaSitagliptin Phosphate16$8,768
Breo ElliptaFluticasone/Vilanterol11$4,545
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$2,351
Potassium Chloride47$2,067
Atorvastatin Calcium135$1,449
Pregabalin19$520
Losartan Potassium69$518
Omeprazole32$453
Levothyroxine Sodium57$433
Duloxetine Hcl27$429
Montelukast Sodium40$428
Gabapentin51$398

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$102$22,36615 claims
PfizerEliquis$43$20,87128 claims
Lilly USA, LLCMounjaro$16$18,04516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,246 physician assistant providers in Louisiana.

Other physician assistant in Shreveport

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →